Finance: Page 6

No Deal: Cresco Labs, Columbia Care Call Off $2-Billion Merger

The multistate cannabis operators terminated an acquisition agreement dating back to March 2022; the Sean “Diddy” Combs deal is off, too.

Mastercard No Longer Allowing Cannabis Purchases on Debit Cards

The corporation is the latest payment processor warning financial firms not to service the cannabis industry.

Cannabis Financial Industry Group Releases Cannabis Banking Standards

The coalition published the resource to help financial institutions understand strict compliance policies as the SAFE Banking debate continues in Congress.

Where the Cresco-Columbia Care Merger Stands on Deadline Day

The multistate cannabis operators continue to work “amicably” on their definitive agreement.

‘Successful in Any Environment’

Colin Kelley of Merida Capital Holdings shares insights into how cannabis businesses can shift from reacting to planning ahead to withstand volatile market conditions.

TerrAscend Closes US$25 Million Commercial Loan With Stearns Bank

The proceeds will be used to pay down higher-interest debt, reducing the company’s overall interest expense.

Inside the Collapse of California Distribution Giant Herbl

Stakeholders weigh in on the company’s receivership and where the market could go from here.

Canopy Growth Files Revised Proxy Statement, Modifies Canopy USA Structure to Comply With Nasdaq Requirements

The company is advancing its Canopy USA strategy, designed to accelerate entry into the U.S. cannabis market.

Trulieve, Verano, Ascend Wellness Buckle Up for New Growth Markets

Reporting first quarter financials, CEOs from the three multistate operators are now regearing for more favorable business conditions.

Curaleaf’s Boris Jordan Says New Super PAC Will Sway SAFE Banking’s Passage in 2023

The company’s executive chairman provided a timeline for the bill during an earnings call but said he’s not “predicting anything in Washington.”

Curaleaf to Restate Certain Previously Issued 2022 and 2021 Financial Statements

The company will report minor reductions in revenue of approximately 1.25% and 0.75% for 2021 and 2022, respectively.

Verano CEO Says 2023 Will Be ‘Inflection Point’ for Cannabis Industry

As smaller operators struggle to weather the industry downturn, George Archos forecasts favorable M&A deals in attractive markets.

Previous Page

Page 6 of 184

Next Page